Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001012975-17-000157

Director sold 135,364 shares at an average $49.37 ($6,683,464)

  • Director acquired 61,564 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
NELSEN ROBERT Director 2017-02-21 Sale −1,780 $54.17 $96,428 417,265 I: show line 1 in the form
NELSEN ROBERT Director 2017-02-21 Sale −34,650 $50.56 $1,751,821 382,615 I: show line 2 in the form
NELSEN ROBERT Director 2017-02-22 Sale −46,938 $49.90 $2,342,408 335,677 I: show line 3 in the form
NELSEN ROBERT Director 2017-02-22 Sale −1,000 $50.35 $50,346 334,677 I: show line 4 in the form
NELSEN ROBERT Director 2017-02-23 Sale −42,596 $47.73 $2,032,979 292,081 I: show line 5 in the form
NELSEN ROBERT Director 2017-02-23 Sale −8,400 $48.75 $409,482 283,681 I: show line 6 in the form
NELSEN ROBERT Director 2016-06-30 Other acquisition +25,412 73,078 D: show line 7 in the form
NELSEN ROBERT Director 2016-08-08 Other acquisition +36,152 109,230 D: show line 8 in the form
Open-market sales · 135,364 sh · avg $49.37 · $6,683,464
Loading xslF345X03/edgar.xml…